What we do

We provide reliable knowledge service to pharmaceutical and investment clients by procuring meaningful information about current progress and opinions concerning drug discovery and development, technology and therapeutic areas, scientific and medical literature.

Who we are

Connotia is a global network of research analysts, that are united by a mission to become independent knowledge acquirers that exceed client expectations.

We are not a corporation tied to earnings pressures and industry regulations, but an organization free to take an unbiased perspective on drug pipelines with respect to the underlying scientific, clinical, regulatory and financial intelligence.

What we believe

Connotia is built on the principles of acquiring knowledge to help others - consultants and clients - in making strategic, competitive and investment decisions.

Our diversified services provide the most comprehensive perspective on pharmaceutical advances by identifying trends, by recognizing improvements, and by mincing the details.

How we started

Picking winners amongst pharmaceutical companies is as hard as picking winners amongst drugs by a pharmaceutical company. Traditional fundamentals and metrics fail to differentiate trends.

We bellieve that the Pharmaceutical sector is a jungle with big carnivores, mid-size monkeys and small pests. The survival requires understanding the behavior of every beast, the lay of every stretch of land, the movement of every creeper and crawler, the unseasonal change in the color of leaves, and the map of leading trails.

Our approach is to perceive all, and highlight the knowledge that matters.